![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 14, 2017 9:00:36 PM
Step 1. RATD decision by FDA, if affirmative, will move the PPS northward quite a bit.
Step 2. Results of clinical trials, could be released within the next few weeks/months or earlier. If results are positive and robust, the PPS would move upward fast and furiously.
Step 3. Fast track designation by FDA, if granted, will produce strong positive effects on PPS. I believe RATD and fast track designation are some how connected (but not sure 100%).
Step 4. FDA decision on the drug approval submission, if affirmative, will move the PPS up in an epic proportion.
Needless to say, if step 2 is negative, then steps 3 and 4 would not follow, until such time when the company re-submits.
Meanwhile, if steps 1 and 2 are positive, there could be a buyout offer on the table. All bets are off in this scenario.
I expect all the four steps could be completed within a reasonable time frame, depending upon how close the company is with respect to finishing the clinical trials.
If all the four steps come to fruition in a positive manner, the PPS could be trading in the dollar land. We'll see.
Go $$USRM$$
All imho, not an investment advice. Do your own DD and trade at your own risks.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM